Biomerica, Inc. (NASDAQ:BMRA) Short Interest Update

Biomerica, Inc. (NASDAQ:BMRA) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 371,700 shares, a decrease of 33.9% from the October 31st total of 562,400 shares. Based on an average daily trading volume, of 442,900 shares, the short-interest ratio is currently 0.8 days.

Biomerica Trading Up 20.9 %

Shares of NASDAQ:BMRA traded up $0.07 on Friday, reaching $0.39. 25,051,793 shares of the company traded hands, compared to its average volume of 382,753. The stock has a market capitalization of $6.55 million, a P/E ratio of -1.05 and a beta of -1.13. The business’s 50-day simple moving average is $0.34 and its 200 day simple moving average is $0.40. Biomerica has a 52 week low of $0.24 and a 52 week high of $2.13.

Biomerica (NASDAQ:BMRA) last announced its quarterly earnings results on Tuesday, October 15th. The company reported ($0.08) earnings per share for the quarter. Biomerica had a negative net margin of 111.89% and a negative return on equity of 84.62%. The firm had revenue of $1.81 million for the quarter.

Hedge Funds Weigh In On Biomerica

An institutional investor recently raised its position in Biomerica stock. Russell Investments Group Ltd. raised its stake in shares of Biomerica, Inc. (NASDAQ:BMRA) by 11.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 225,435 shares of the company’s stock after purchasing an additional 23,872 shares during the quarter. Russell Investments Group Ltd. owned approximately 1.34% of Biomerica worth $188,000 at the end of the most recent reporting period. Institutional investors own 22.28% of the company’s stock.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.